CD44 and neoplasm: HMSN–PA–HA could effectively accumulate at tumor sites by HA and CD44 interactions and release loaded drugs when hydrazine linkers between HA agents and HMSNs were broken, triggered by the low pH in the tumor microenvironment (Dai et al., 2016).